Thomas Trimarchi - 12 Dec 2025 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role: President and CFO
Signature: /s/ Will Solis, Attorney-in-Fact
Issuer symbol: BBIO
Transactions as of: 12 Dec 2025
Net transactions value: -$1,039,024
Form type: 4
Filing time: 16 Dec 2025, 18:25:44 UTC
Previous filing: 18 Nov 2025
Next filing: 18 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Trimarchi Thomas	President and CFO	C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO	/s/ Will Solis, Attorney-in-Fact	16 Dec 2025	0002030813

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BBIO	Common Stock	Tax liability	$1,039,024	-13,826	-3.6%	$75.15	369,004	12 Dec 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 25,000 shares of Common Stock underlying the Reporting Person's Restricted Stock Units.